Overview

Cord Blood Expansion on Mesenchymal Stem Cells

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if combining cord blood units will be safe and result in the cells "taking" faster in recipients. The cord blood units will have their cell number increased in the lab using cells from a family member or they will be collected from an unrelated healthy donor.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
ViaCell
Treatments:
Antilymphocyte Serum
Busulfan
Clofarabine
Cyclophosphamide
Fludarabine
Fludarabine phosphate
Melphalan
Mycophenolate mofetil
Mycophenolic Acid
Rituximab
Tacrolimus
Thymoglobulin
Vidarabine